Researchers Discover How Alzheimer’s Protein Behaves in Healthy Cells
Lawrence S. B. Goldstein and colleagues at the University of California in San Diego have now discovered how a protein involved in Alzheimers disease—the amyloid precursor protein (APP)—normally behaves in the healthy brain cells of both mice and fruit flies. This information, published today in Nature, suggests an all new mechanism by which Alzheimers might develop and thus opens new paths to explore towards potential therapies.
The researchers focused on APP because it has long been known to degrade into so-called amyloid beta plaques, which are seen in the brains of Alzheimers patients. What had remained mysterious was exactly how and where APP generates amyloid beta—and why that should lead to brain cell death. All cells in the body normally produce amyloid beta, Goldstein says, „thats why we asked what was special about neurons that made them susceptible to damage caused by APP.“
They found that APP plays an important role in moving signals through axons—the projections along which neurons communicate. In fruit flies, they showed that a lack of APP hindered the neurons ability to send materials through axons. Too much APP clogged the axonal system and killed the neurons. These experiments appeared in Neuron last month. In the new report, they demonstrate in a mouse model that the transport system in question moves two enzymes—beta-secretase (Bace) and presenilin—that also seem to be responsible for breaking APP down into amyloid beta.
„Once amyloid beta has been generated, it is possible that the axonal pathway becomes physically blocked,“ Goldstein says. „Were suggesting that with this blockage, a signal is generated saying that traffic is blocked and the neuron should die. Although this is only a first step in understanding the connection between APP, axonal transport and the location where amyloid beta is produced during disease, our work offers a possible approach for the eventual design of new Alzheimers therapies that directly target amyloid beta and APP transport.“
Media Contact
Weitere Informationen:
http://www.sciam.com/news/120601/2.htmlAlle Nachrichten aus der Kategorie: Medizin Gesundheit
Dieser Fachbereich fasst die Vielzahl der medizinischen Fachrichtungen aus dem Bereich der Humanmedizin zusammen.
Unter anderem finden Sie hier Berichte aus den Teilbereichen: Anästhesiologie, Anatomie, Chirurgie, Humangenetik, Hygiene und Umweltmedizin, Innere Medizin, Neurologie, Pharmakologie, Physiologie, Urologie oder Zahnmedizin.
Neueste Beiträge
Bakterien für klimaneutrale Chemikalien der Zukunft
Forschende an der ETH Zürich haben Bakterien im Labor so herangezüchtet, dass sie Methanol effizient verwerten können. Jetzt lässt sich der Stoffwechsel dieser Bakterien anzapfen, um wertvolle Produkte herzustellen, die…
Batterien: Heute die Materialien von morgen modellieren
Welche Faktoren bestimmen, wie schnell sich eine Batterie laden lässt? Dieser und weiteren Fragen gehen Forschende am Karlsruher Institut für Technologie (KIT) mit computergestützten Simulationen nach. Mikrostrukturmodelle tragen dazu bei,…
Porosität von Sedimentgestein mit Neutronen untersucht
Forschung am FRM II zu geologischen Lagerstätten. Dauerhafte unterirdische Lagerung von CO2 Poren so klein wie Bakterien Porenmessung mit Neutronen auf den Nanometer genau Ob Sedimentgesteine fossile Kohlenwasserstoffe speichern können…